RESMED INC — Director's Dealing 2022

Jul 26, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2022-07-22

Reporting Person: Sandercock Brett (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-22	ResMed Common Stock	M	2500	$57.76	Acquired	108926	Direct
2022-07-22	ResMed Common Stock	M	2500	$57.76	Acquired	111426	Direct
2022-07-22	ResMed Common Stock	M	2500	$57.76	Acquired	113926	Direct
2022-07-22	ResMed Common Stock	S	7500	$235.00	Disposed	106426	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-07-22	ResMed Common Stock Options	$57.76	M	2500	Disposed	2023-11-16	ResMed Common Stock (2500)	Direct
2022-07-22	ResMed Common Stock Options	$57.76	M	2500	Disposed	2023-11-16	ResMed Common Stock (2500)	Direct
2022-07-22	ResMed Common Stock Options	$57.76	M	2500	Disposed	2023-11-16	ResMed Common Stock (2500)	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: Includes 71.359 shares of ResMed stock purchased on April 29, 2022, through the ResMed Employee Stock Purchase Plan.

F3: Represents date options first became exercisable. Options vest 1/3 per year.